Dr. Hamouda is Sr. Med. Director at Pfenex Inc. where he is managing clinical trials and is working on the development of recombinant anthrax vaccine. Prior to this he was working at NanoBio on the development of nanoemulsion adjuvanted nasal vaccine against genital herpes, RSV, influenza and anthrax. He was also involved in the development of broad spectrum antimicrobial nonoemotions. His PhD is in immunology and Microbiology.